What is the appropriate workup for evaluating polycystic ovary syndrome in a reproductive‑age woman presenting with menstrual irregularities, hyperandrogenic signs, or infertility?

PCOS Workup

Diagnose PCOS using the Rotterdam criteria when at least two of three features are present: oligo/anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound—after excluding mimicking disorders. 1, 2

Clinical History and Physical Examination

Document the following specific elements:

• Menstrual pattern: Cycle length >35 days suggests chronic anovulation; track for at least 6 months to establish oligomenorrhea, polymenorrhea, or amenorrhea 1, 3
• Onset and duration of androgen-excess signs (acne, hirsutism, male-pattern hair loss) 1
• Medication review: Identify use of exogenous androgens or hormonal contraceptives that may confound testing 1
• Family history of cardiovascular disease, diabetes, and PCOS 1
• Lifestyle factors: Diet, exercise patterns, alcohol use, smoking 1

Physical examination must include:

• Hyperandrogenism signs: Acne distribution, male-pattern balding, hirsutism (use Ferriman-Gallwey score), clitoromegaly 1, 3
• Insulin resistance markers: Acanthosis nigricans at neck, axillae, groin 1
• Body metrics: Calculate BMI and waist-hip ratio 1
• Features suggesting alternate diagnoses: Buffalo hump, moon facies, hypertension, abdominal striae (Cushing's), rapid virilization (androgen-secreting tumor) 1, 3

Laboratory Testing

First-Line Hormonal Assessment

Measure total testosterone via liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the single best initial biochemical marker, with 74% sensitivity and 86% specificity 1, 3. Alternatively, calculated free testosterone (using the Vermeulen equation from high-quality total testosterone and SHBG) demonstrates superior sensitivity of 89% with 83% specificity 1.

Critical caveat: 30% of women with confirmed PCOS have normal testosterone levels, so normal results do not exclude the diagnosis 3. Do not use direct immunoassay for free testosterone—it is inaccurate 1.

Mandatory Exclusion Tests

• TSH: Rule out thyroid disease 1, 3
• Morning resting prolactin: Exclude hyperprolactinemia; women with PCOS have a 3.15-fold increased risk of elevated prolactin 1
• 17-hydroxyprogesterone (early morning): Screen for non-classic congenital adrenal hyperplasia 1

Additional Androgen Markers (When Indicated)

• Androstenedione (A4): 75% sensitivity, 71% specificity; useful when SHBG is low 1
• DHEAS: 75% sensitivity, 67% specificity; most reliable for adrenal androgen production, particularly valuable in women <30 years 1
• Free androgen index (FAI): 78% sensitivity, 85% specificity; caution when SHBG <30 nmol/L 1

Metabolic Screening (Mandatory for All PCOS Patients)

All women with PCOS require metabolic assessment regardless of BMI, because insulin resistance occurs independently of body weight 1:

• 2-hour oral glucose tolerance test with 75-gram glucose load 1, 3
• Fasting lipid profile (total cholesterol, LDL, HDL, triglycerides) 1, 3
• Fasting glucose and insulin with glucose/insulin ratio calculation 4

A fasting glucose >7.8 mmol/L suggests diabetes; glucose/insulin ratio >4 suggests reduced insulin sensitivity 4.

Imaging Assessment

Transvaginal Ultrasound

Perform transvaginal ultrasound with ≥8 MHz transducer frequency to assess polycystic ovarian morphology 4, 1, 3. The ultrasound must document:

• Follicle count: ≥20 follicles (2–9 mm diameter) per ovary is the gold standard marker, with 87.64% sensitivity and 93.74% specificity 4, 1, 3
• Ovarian volume: >10 mL in at least one ovary is diagnostic, with 81.48% sensitivity and 81.04% specificity 4, 1, 3

When follicle counting is technically difficult, ovarian volume >10 mL serves as an alternative diagnostic threshold 4, 1.

Age-Specific Ultrasound Considerations

Do not use ultrasound as a first-line diagnostic tool in adolescents (<20 years, at least 1 year post-menarche or <8 years post-menarche) due to poor specificity and high false-positive rates from normal multifollicular ovaries 4, 1, 5. In adolescents, rely on clinical and biochemical hyperandrogenism plus menstrual irregularity persisting 2–3 years beyond menarche 1.

Anti-Müllerian Hormone (AMH)

Do not use AMH for PCOS diagnosis despite significantly elevated levels in PCOS women, because of lack of assay standardization, no validated cut-offs, significant overlap between women with and without PCOS, and age-dependent variability 1.

Diagnostic Algorithm

Apply the Rotterdam criteria—diagnosis requires 2 of 3 features 1, 3, 2:

1. Irregular cycles + clinical/biochemical hyperandrogenism → PCOS confirmed without ultrasound 3
2. Irregular cycles + polycystic ovaries on ultrasound (without hyperandrogenism) → PCOS confirmed 3
3. Hyperandrogenism + polycystic ovaries (with regular cycles) → PCOS confirmed 3

Important: Up to one-third of reproductive-aged women without PCOS have polycystic ovarian morphology on ultrasound, so imaging findings alone are insufficient 1.

Excluding Mimicking Disorders

Before confirming PCOS, systematically exclude:

• Cushing's syndrome: Screen when buffalo hump, moon facies, hypertension, abdominal striae, central obesity, easy bruising, or proximal myopathy are present 1, 3
• Androgen-secreting tumors (ovary or adrenal): Suspect with rapid onset of severe virilization, marked clitoromegaly, voice deepening, or very high testosterone levels 1, 3
• Non-classic congenital adrenal hyperplasia: Measure 17-hydroxyprogesterone 1
• Primary ovarian failure: Check FSH; levels >35–50 IU/L suggest premature ovarian insufficiency 4, 3
• Acromegaly: Evaluate when compatible clinical signs are present 1
• Hypothalamic amenorrhea: Consider in the context of excessive exercise or low body weight 4

Additional Screening and Monitoring

Cardiovascular and Metabolic Surveillance

• Blood pressure: Measure at least annually 1
• Body weight/BMI: Track every 6–12 months; even 5% weight loss improves metabolic and reproductive abnormalities 1
• Fasting lipid profile: Annually 1
• Glucose monitoring: Regularly (e.g., annually or per risk stratification) 1

Vitamin D Assessment

Measure serum 25-hydroxy-vitamin D in all women with PCOS, as deficiency is present in 67–85% of this population 1. Note that vitamin D behaves as a negative acute-phase reactant, so inflammatory states can lower circulating levels 1.

Psychological Screening

Formally screen for anxiety, depression, body-image concerns, and eating-disorder pathology at baseline and periodically (e.g., annually), because these conditions are highly prevalent in PCOS 1.

Common Pitfalls to Avoid

• Do not diagnose PCOS in women currently using hormonal contraception (including progestin-only implants like Implanon), as these suppress the hypothalamic-pituitary-ovarian axis and render hormone levels unreliable; remove or allow expiration before testing 1
• Do not dismiss small ovarian volume as insignificant: Ovarian volume <3 cm³ with <5 antral follicles suggests diminished ovarian reserve, not PCOS, and warrants investigation for premature ovarian insufficiency 4, 6
• Do not rely on direct immunoassay for free testosterone—it is inaccurate; use calculated free testosterone instead 1
• Do not use ultrasound criteria in adolescents due to high false-positive rates 4, 1, 5
• Do not overlook metabolic screening in normal-weight women, as insulin resistance occurs independently of BMI 1